Hervé Perron Selected Research

env Gene Products

4/2021	Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients.
1/2021	Identification of inflammatory subgroups of schizophrenia and bipolar disorder patients with HERV-W ENV antigenemia by unsupervised cluster analysis.
4/2016	Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
1/2015	Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.
11/2013	Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation.
12/2012	GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study.
12/2008	Endogenous retrovirus type W GAG and envelope protein antigenemia in serum of schizophrenic patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hervé Perron Research Topics

Disease

28	Multiple Sclerosis 10/2021 - 02/2005
5	Inflammation (Inflammations) 07/2016 - 12/2008
3	Schizophrenia (Dementia Praecox) 01/2021 - 12/2008
3	Infections 09/2020 - 03/2006
3	Prion Diseases (Transmissible Spongiform Encephalopathies) 04/2009 - 08/2006
3	Scrapie 08/2008 - 08/2006
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2020 - 01/2018
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2017 - 02/2017
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 04/2009 - 08/2006
1	Disease Progression 04/2021
1	COVID-19 04/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Neoplasms (Cancer) 07/2020
1	Hyperglycemia 01/2017
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 04/2016
1	Encephalitis (Encephalitis, Rasmussen) 01/2015
1	Human Influenza (Influenza) 03/2013
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2013
1	Neuroinflammatory Diseases 01/2013
1	Persistent Infection 12/2012
1	Dementia (Dementias) 04/2009
1	Bovine Spongiform Encephalopathy (Mad Cow Disease) 08/2006

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 09/2020 - 02/2005
7	env Gene ProductsIBA 04/2021 - 12/2008
7	temelimabIBA 01/2018 - 12/2012
7	ElementsIBA 01/2013 - 02/2005
6	Monoclonal AntibodiesIBA 01/2018 - 12/2012
5	Streptomycin (Streptomycin Sulfate)FDA Link 04/2009 - 03/2006
4	Biomarkers (Surrogate Marker)IBA 04/2021 - 12/2008
4	Biological ProductsIBA 01/2021 - 01/2009
4	AntigensIBA 01/2013 - 02/2005
3	CytokinesIBA 04/2021 - 03/2005
3	Prion ProteinsIBA 05/2008 - 03/2006
2	syncytinIBA 10/2021 - 07/2016
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2021 - 01/2013
2	Toll-Like Receptor 4IBA 02/2016 - 12/2012
2	Immunoglobulin G (IgG)IBA 06/2015 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 02/2005
2	RNA (Ribonucleic Acid)IBA 08/2010 - 11/2009
2	PrPSc ProteinsIBA 04/2009 - 08/2008
2	PrionsIBA 05/2008 - 03/2006
1	Chlorpromazine (Thorazine)FDA Link 01/2021
1	Messenger RNA (mRNA)IBA 09/2020
1	DNA Transposable Elements (Element, IS)IBA 07/2020
1	Retroelements (Retrotransposon)IBA 02/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Interleukin-6 (Interleukin 6)IBA 04/2016
1	Neutralizing AntibodiesIBA 04/2016
1	Immunoglobulins (Immunoglobulin)IBA 06/2015
1	Myelin ProteinsIBA 01/2013
1	Freund's AdjuvantIBA 01/2013
1	C-Reactive ProteinIBA 12/2008
1	AntibodiesIBA 08/2006

Therapy/Procedure

1	Therapeutics 07/2016
1	Precision Medicine 10/2015